Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
Jacobson, J M
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. [electronic resource] - The New England journal of medicine May 1997 - 1487-93 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0028-4793
10.1056/NEJM199705223362103 doi
Acquired Immunodeficiency Syndrome--complications
Adult
Double-Blind Method
Female
HIV-1--drug effects
Humans
Male
Quality of Life
Receptors, Tumor Necrosis Factor--blood
Stomatitis, Aphthous--drug therapy
Thalidomide--adverse effects
Treatment Outcome
Tumor Necrosis Factor-alpha--analysis
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. [electronic resource] - The New England journal of medicine May 1997 - 1487-93 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0028-4793
10.1056/NEJM199705223362103 doi
Acquired Immunodeficiency Syndrome--complications
Adult
Double-Blind Method
Female
HIV-1--drug effects
Humans
Male
Quality of Life
Receptors, Tumor Necrosis Factor--blood
Stomatitis, Aphthous--drug therapy
Thalidomide--adverse effects
Treatment Outcome
Tumor Necrosis Factor-alpha--analysis